164 related articles for article (PubMed ID: 38333510)
1. Comparative Efficacy of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Agents and Corticosteroids in Managing Diabetic Retinopathy-Associated Diabetic Macular Edema: A Meta-Analysis and Comprehensive Systematic Review.
Kumar A; Kumar A; Kumar J; Bai G; Jeewnani R; Dembra M; Kanwal K; Qadeer U; Khawar MH; Yaseen Khan I; Ram R; Varrassi G
Cureus; 2024 Jan; 16(1):e51910. PubMed ID: 38333510
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis.
Chen J; Wang H; Qiu W
Front Endocrinol (Lausanne); 2023; 14():1096105. PubMed ID: 36817588
[TBL] [Abstract][Full Text] [Related]
6. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
7. Intravitreal Steroids Compared with Anti-VEGF Treatment for Diabetic Macular Edema: A Meta-Analysis.
Patil NS; Mihalache A; Hatamnejad A; Popovic MM; Kertes PJ; Muni RH
Ophthalmol Retina; 2023 Apr; 7(4):289-299. PubMed ID: 36272716
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
He Y; Ren XJ; Hu BJ; Lam WC; Li XR
BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
[TBL] [Abstract][Full Text] [Related]
10. Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Cui L; Jiao B; Han Q
Diabetes Ther; 2019 Aug; 10(4):1283-1296. PubMed ID: 31079358
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis.
Ji K; Zhang Q; Tian M; Xing Y
Medicine (Baltimore); 2019 May; 98(22):e15798. PubMed ID: 31145307
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.
Liu WS; Li YJ
Int J Ophthalmol; 2019; 12(9):1479-1486. PubMed ID: 31544046
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: A systematic review and meta-analysis.
Gong Y; Wang M; Li Q; Shao Y; Li X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103555. PubMed ID: 37088331
[TBL] [Abstract][Full Text] [Related]
14. Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection.
Maeda S; Sugimoto M; Tenma Y; Tsukitome H; Kato K; Chujo S; Matsui Y; Matsubara H; Kondo M
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362644
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema.
Koc H; Alpay A; Ugurbas SH
BMC Ophthalmol; 2023 Mar; 23(1):97. PubMed ID: 36915060
[TBL] [Abstract][Full Text] [Related]
17. Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy.
Chakraborty S; Ganguly S; Sheth JU
Clin Ophthalmol; 2024; 18():227-233. PubMed ID: 38283181
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
Mi X; Gu X; Yu X
Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
[TBL] [Abstract][Full Text] [Related]
19. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
20. Evaluating initial responses to brolucizumab in patients undergoing conventional anti-VEGF therapy for diabetic macular edema: a retrospective, single-center, observational study.
Hirano T; Kumazaki A; Tomihara R; Ito S; Hoshiyama K; Murata T
Sci Rep; 2023 Jul; 13(1):10901. PubMed ID: 37407660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]